PL2341937T3 - Kompozycja do leczenia choroby - Google Patents

Kompozycja do leczenia choroby

Info

Publication number
PL2341937T3
PL2341937T3 PL09782400T PL09782400T PL2341937T3 PL 2341937 T3 PL2341937 T3 PL 2341937T3 PL 09782400 T PL09782400 T PL 09782400T PL 09782400 T PL09782400 T PL 09782400T PL 2341937 T3 PL2341937 T3 PL 2341937T3
Authority
PL
Poland
Prior art keywords
composition
treating disease
disease
treating
Prior art date
Application number
PL09782400T
Other languages
English (en)
Inventor
Frank Osterroth
Silke Aigner
Christoph Uherek
Andrea Wartenberg-Demand
Anatoly Rudnev
Michael Soldan
Christoph Bruecher
Benjamin Daelken
Chantal Zuber
Gregor Schulz
Niklas Czeloth
Original Assignee
Biotest Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0817809A external-priority patent/GB0817809D0/en
Priority claimed from GB0817811A external-priority patent/GB0817811D0/en
Priority claimed from GB0817810A external-priority patent/GB0817810D0/en
Priority claimed from PCT/EP2009/052811 external-priority patent/WO2009124815A1/en
Priority claimed from PCT/EP2009/052810 external-priority patent/WO2009112502A1/en
Priority claimed from PCT/EP2009/052809 external-priority patent/WO2009121690A1/en
Application filed by Biotest Ag filed Critical Biotest Ag
Priority claimed from PCT/EP2009/061210 external-priority patent/WO2010034590A1/en
Publication of PL2341937T3 publication Critical patent/PL2341937T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • C07K16/2812—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against CD4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
    • A61K39/39541—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against normal tissues, cells
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Mycology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
PL09782400T 2008-09-29 2009-08-31 Kompozycja do leczenia choroby PL2341937T3 (pl)

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
GB0817809A GB0817809D0 (en) 2008-09-29 2008-09-29 Agent for treating disease
GB0817811A GB0817811D0 (en) 2008-09-29 2008-09-29 Agent for treating disease
GB0817810A GB0817810D0 (en) 2008-09-29 2008-09-29 Agent for treating disease
PCT/EP2009/052811 WO2009124815A1 (en) 2008-03-13 2009-03-10 Agent for treating disease
PCT/EP2009/052810 WO2009112502A1 (en) 2008-03-13 2009-03-10 Agent for treating disease
PCT/EP2009/052809 WO2009121690A1 (en) 2008-03-13 2009-03-10 Agent for treating disease
PCT/EP2009/061210 WO2010034590A1 (en) 2008-09-29 2009-08-31 Composition for treating disease
EP09782400.7A EP2341937B1 (en) 2008-09-29 2009-08-31 Composition for treating disease

Publications (1)

Publication Number Publication Date
PL2341937T3 true PL2341937T3 (pl) 2015-05-29

Family

ID=44123305

Family Applications (1)

Application Number Title Priority Date Filing Date
PL09782400T PL2341937T3 (pl) 2008-09-29 2009-08-31 Kompozycja do leczenia choroby

Country Status (4)

Country Link
EP (1) EP2341937B1 (pl)
HR (1) HRP20150238T1 (pl)
PL (1) PL2341937T3 (pl)
SI (1) SI2341937T1 (pl)

Also Published As

Publication number Publication date
EP2341937A1 (en) 2011-07-13
SI2341937T1 (sl) 2015-03-31
EP2341937B1 (en) 2014-12-17
HRP20150238T1 (hr) 2015-04-10

Similar Documents

Publication Publication Date Title
ZA201007216B (en) Agent for treating disease
IL207892A0 (en) Agent for treating disease
ZA201007215B (en) Agent for treating disease
IL257418A (en) Methods for treating addiction
IL209895A0 (en) Compounds for treating beta-amyloidoses
EP2322076A4 (en) ENDOSCOPE OF TREATMENT
EP2282826A4 (en) PROCESS FOR TREATMENT OF ODOR
GB0802116D0 (en) Treatment
ZA201204845B (en) Agents for treating disease
SG10201408508YA (en) Combination composition useful for treating cardiovascular diseases
TWI367274B (en) Composition for fabric treatment
PT2341937E (pt) Composição para tratamento de doença
GB0811992D0 (en) Treatment
EP2174956A4 (en) COMPOSITIONS FOR ANTIFIBRINOLYSIS THERAPY
EP2255825A4 (en) COMPOSITION FOR PREVENTING OR TREATING BRAIN DISEASES
ZA201009226B (en) Nifurtimox for treating disease caused by trichomonadida
GB0820972D0 (en) Treatment
GB0805912D0 (en) Treatment
PL384259A1 (pl) Kompozycja farmaceutyczna do leczenia chorób skórnych
PL2341937T3 (pl) Kompozycja do leczenia choroby
GB0817811D0 (en) Agent for treating disease
GB0817810D0 (en) Agent for treating disease
GB0817809D0 (en) Agent for treating disease
GB0818713D0 (en) Substances useful for treating diseases
GB0700578D0 (en) Composition for treating blood conditions